NEW YORK, June 5, 2023 /PRNewswire/ -- Attention Reata Pharmaceuticals, Inc. ("Reata") (NASDAQ:RETA) shareholders:
The Law Offices of Vincent Wong announce that an investigation has commenced into Reata and certain of its officers and directors regarding potential securities fraud. The investigation concerns, in part, the below:
Read more at prnewswire.com